Figure 2.
![Cumulative incidence of CNS relapse for patients with aaIPI of 2 to 3 according to first-line therapy (R-ACVBP vs R-CHO[E]P). Adjusted hazard ratio (HR) with 95% CI is presented.](https://ash.silverchair-cdn.com/ash/content_public/journal/bloodadvances/7/15/10.1182_bloodadvances.2022008888/2/blooda_adv-2022-008888-gr2.jpeg?Expires=1724944805&Signature=t1bchgXAJTXjAMGmBo-Dwn1-G4FOL~eKpXElo1C22ydeLkJiSX0WGvHlLBfj3fT9C3pPXpaTP-nbtR-m1KqLnuQDBlQgVBbf9jnHzgaBszYF8An6TTMnPL~sxLBAN47LkhhKKgooNv82LQbzcoKb-7CJGoSl8UdUWW6KKJqtjZV~efLPawNbngF0fivnXAzn-RqOPPyXuY65wT9iFZ2ORTSvgCznN9aZ9rWpOnoRe3x3dX8RJ~8rhW~NulpldgXMQaz6Olr2BthvqmW5NYU7BkPVzTFa18JpNGc6~e3eQqBw01KPScdOilS3lcZKsbAI3X-9CZwmOddcTMaJAhdjAg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Cumulative incidence of CNS relapse for patients with aaIPI of 2 to 3 according to first-line therapy (R-ACVBP vs R-CHO[E]P). Adjusted hazard ratio (HR) with 95% CI is presented.
Cumulative incidence of CNS relapse for patients with aaIPI of 2 to 3 according to first-line therapy (R-ACVBP vs R-CHO[E]P). Adjusted hazard ratio (HR) with 95% CI is presented.
